# Steroids and Surfactant in Extremely Low Gestation Age Infants Dose Escalation Trial

> **NCT02907593** · PHASE1,PHASE2 · TERMINATED · sponsor: **Cynthia McEvoy** · enrollment: 25 (actual)

## Conditions studied

- Bronchopulmonary Dysplasia (BPD)

## Interventions

- **DRUG:** Budesonide in Calfactant

## Key facts

- **NCT ID:** NCT02907593
- **Lead sponsor:** Cynthia McEvoy
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-09
- **Primary completion:** 2018-04
- **Final completion:** 2018-04
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2025-04-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02907593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02907593, "Steroids and Surfactant in Extremely Low Gestation Age Infants Dose Escalation Trial". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02907593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*